Max Healthcare Institute (MAXHEALT) reported strong EBITDA growth of 23% YoY to Rs 6.94bn. The company showed phenomenal growth with ~19% EBITDA CAGR over FY22-25. We expect pick-up in the growth ...
2QFY26 APE grew 15% YoY driven by NPAR and protection and company expects the momentum to continue. We build an APE growth of 16% in FY26 driven by a strong uptick in retail protection post GST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback